Tags:BioTechLifeManufacturingTechnologyWebsite
DNA Script is the world’s leading company in manufacturing de novo synthetic nucleic acids using an enzymatic technology. The company aims at accelerating innovation in life sciences and technology through rapid, affordable, and high-quality DNA synthesis. DNA Script’s approach leverages nature's billions of years of evolution in synthesizing DNA to enable genome scale synthesis.
Total raised: $311.169094M
Investors 5
Funding Rounds 5
Mentions in press and media 10
| Date | Title | Description | Source |
| 11.12.2021 | DNA Script Raises $165M in Oversubscribed Series C Financing... | New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Tot... | m-ventures... |
| 17.05.2019 | DNA Script picks up $38.5 million to make DNA production fas... | DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is th... | techcrunch... |
| 17.05.2019 | Term Sheet — Friday, May 17 | AMAZON VS. UBER
The food delivery wars are heating up in very interesting ways.
Paid Content Secur... | fortune.co... |
| 16.05.2019 | Daily funding roundup - May 16th, 2019 | Core raises $4M; Retail Zipline secured $9.6M; Sawyer closed $11M; OpenFin landed $17M
Core: Core i... | vator.tv/n... |
| 16.05.2019 | Paris-based biotech startup DNA Script raises €34.4 million ... | DNA Script is a biotech company developing devices and methods to more quickly and affordably synthe... | eu-startup... |
| 16.05.2019 | DNA Script Secures $38.5M in Series B Funding | DNA Script, a Paris, France-based maker of de novo synthetic nucleic acids using an enzymatic techno... | finsmes.co... |
| 04.04.2018 | DNA Script Receives $5.5M in Innovation Grants | DNA Script, a Paris, France-based developer of enzymatic DNA synthesis technology, received $5.5M in... | finsmes.co... |
| 13.09.2017 | Term Sheet — Wednesday, September 13 | CRYPTO DRAMA
JAMIE DIMON VS. THE INTERNET: J.P. Morgan CEO Jamie Dimon lit the Internet on fire yes... | fortune.co... |
| 12.09.2017 | DNA Script Raises €11M in Series A Financing | DNA Script, a Paris, France-based Synthetic DNA manufacturer, raised €11m ($13m) in Series A funding... | finsmes.co... |
| - | DNA Script Expands Series B to $89M | Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™️ — the wo... | m-ventures... |
